| Pulmonary veno-occlusive disease due to bleomycin therapy for lymphoma. Case reports. | |
| | |
MedLine Citation:
|
PMID: 6194564 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Two patients with lymphocytic lymphoma and bleomycin-induced pulmonary toxicity were shown at autopsy to have pulmonary venular alterations identical to pulmonary veno-occlusive disease (PVOD). While hepatic veno-occlusive disease due to alkylating agents has been reported, I am unaware of any report of PVOD related to bleomycin therapy. |
| | |
Authors:
|
A G Rose |
Related Documents
:
|
2590904 - Premature ventricular contractions and reflex sympathetic activation in cats. 15055634 - Various clinical situations and their influence on linear occlusion in treating combina... 1126984 - Considerations on occlusive diseases of the leg arteries and determination of muscle bl... 17926944 - Femoropopliteal artery centerline interpolation using contralateral shape. 14682424 - Perinatal three-dimensional color power doppler ultrasonography of vein of galen aneury... 16442114 - Randomized trial of hormone therapy in women after coronary bypass surgery. evidence of... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Volume: 64 ISSN: 0256-9574 ISO Abbreviation: S. Afr. Med. J. Publication Date: 1983 Oct |
Date Detail:
|
Created Date: 1983-11-23 Completed Date: 1983-11-23 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0404520 Medline TA: S Afr Med J Country: SOUTH AFRICA |
Other Details:
|
Languages: eng Pagination: 636-8 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Bleomycin / adverse effects* Constriction, Pathologic / chemically induced Humans Lymphoma / drug therapy* Male Middle Aged Pulmonary Veins / drug effects, pathology* Thrombosis / chemically induced* Venules / pathology |
| Chemical | |
Reg. No./Substance:
|
11056-06-7/Bleomycin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High-frequency transfection and cytopathology of the hepatitis B virus core antigen gene in human ce...
Next Document: Social work services as a component of palliative care with terminal cancer patients.